News
ASCO Annual Meeting 2026 Colorectal Cancer Updates
The American Society of Clinical Oncology (ASCO) Annual Meeting is taking place May 30 – June 3, 2026 in Chicago, Illinois, bringing together oncologists, researchers,...
Ontario becomes first province to publicly fund encorafenib for BRAF-mutant colorectal cancer
Ontario has become the first province in Canada to publicly fund encorafenib (Braftovi) for patients with BRAF V600E-mutant metastatic colorectal cancer, through...
New stool test shows promise for easier colorectal cancer screening
May 2026 Researchers at the University of Geneva have developed a new, non-invasive way to help detect colorectal cancer using...
Hot vs. Cold Tumours: What’s the Difference?
Immunotherapy is changing the way we treat cancer, including colorectal cancer (CRC), but it doesn’t work for everyone. Unlike chemotherapy, which attacks...
Clinical Trial Spotlight: New Immunotherapy for MSS Advanced Colorectal Cancer
A new clinical trial is studying whether a combination of two immunotherapy drugs -botensilimab and balstilimab- can help people with advanced microsatellite stable...
New First-Line Treatment Option for BRAF V600E–Mutant Metastatic Colorectal Cancer
January 2026 Some individuals with metastatic colorectal cancer have a specific genetic change called BRAF V600E. This mutation is linked to faster-growing...
Get social
ASCO Annual Meeting 2026 Colorectal Cancer Updates
The American Society of Clinical Oncology (ASCO) Annual Meeting is taking place May 30 – June 3, 2026 in Chicago, Illinois, bringing together oncologists, researchers,...
Ontario becomes first province to publicly fund encorafenib for BRAF-mutant colorectal cancer
Ontario has become the first province in Canada to publicly fund encorafenib (Braftovi) for patients with BRAF V600E-mutant metastatic colorectal cancer, through...
New stool test shows promise for easier colorectal cancer screening
May 2026 Researchers at the University of Geneva have developed a new, non-invasive way to help detect colorectal cancer using...
Hot vs. Cold Tumours: What’s the Difference?
Immunotherapy is changing the way we treat cancer, including colorectal cancer (CRC), but it doesn’t work for everyone. Unlike chemotherapy, which attacks...
Clinical Trial Spotlight: New Immunotherapy for MSS Advanced Colorectal Cancer
A new clinical trial is studying whether a combination of two immunotherapy drugs -botensilimab and balstilimab- can help people with advanced microsatellite stable...
New First-Line Treatment Option for BRAF V600E–Mutant Metastatic Colorectal Cancer
January 2026 Some individuals with metastatic colorectal cancer have a specific genetic change called BRAF V600E. This mutation is linked to faster-growing...
